Pay in 4 interest-free payments of $7.43 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
GLP-1 receptor activation also inhibits beta cell apoptosis
Originally developed to treat type 2 diabetes, these agonists have been clinically proven to promote significant weight loss by mimicking the effects of the GLP-1 hormone, which plays a crucial role in regulating appetite and blood sugar levels
BPC-157 clinical trial registry search (no active US Phase 1-3 trials)
Orforglipron has shown statistically significant efficacy results and a safety profile consistent with injectable GLP-1 medicines in a successful Phase III trial
US$ 24.40
US$ 25.96
US$ 20.14
US$ 23.85
